Literature DB >> 30930148

Depot formulations to sustain periocular drug delivery to the posterior eye segment.

Yosra Agban1, Sachin S Thakur1, Odunayo O Mugisho1, Ilva D Rupenthal2.   

Abstract

The periocular space is a promising alternative route for the delivery of drugs to the posterior eye segment, especially when treating conditions in the outer ocular layers. In this review, we discuss the different periocular routes as well as the physiological barriers and elimination mechanisms limiting drug bioavailability at the back of the eye. We then highlight various types of depot formulations, including particulate delivery systems, semisolid formulations, and implants, used to increase the contact time with the ocular tissues. With the additional advantage of sustaining drug release, such depot formulations could enhance periocular drug delivery to the posterior eye segment.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2019        PMID: 30930148     DOI: 10.1016/j.drudis.2019.03.023

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  7 in total

Review 1.  Therapeutic implications of nanomedicine for ocular drug delivery.

Authors:  Tuo Meng; Vineet Kulkarni; Russell Simmers; Vikram Brar; Qingguo Xu
Journal:  Drug Discov Today       Date:  2019-05-15       Impact factor: 7.851

2.  Light-responsive biomaterials for ocular drug delivery.

Authors:  Hend A M Abdelmohsen; Nikki A Copeland; John G Hardy
Journal:  Drug Deliv Transl Res       Date:  2022-06-24       Impact factor: 4.617

3.  The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant.

Authors:  Martina Kodetova; Radka Hobzova; Jakub Sirc; Jiri Uhlik; Katerina Dunovska; Karel Svojgr; Ana-Irina Cocarta; Andrea Felsoova; Ondrej Slanar; Martin Sima; Igor Kozak; Pavel Pochop
Journal:  Pharmaceutics       Date:  2022-04-20       Impact factor: 6.525

Review 4.  Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.

Authors:  Sherif A Gaballa; Uday B Kompella; Omar Elgarhy; Ali M Alqahtani; Barbara Pierscionek; Raid G Alany; Hamdy Abdelkader
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

5.  Efficacy of Sub-Tenon Micro-Perfusion of Cyclophosphamide in Rabbits with Severe Ocular Inflammation.

Authors:  Libei Zhao; Manqiang Peng; Wenxiang Lin; Qian Tan; Muhammad Ahmad Khan; Ding Lin
Journal:  Drug Des Devel Ther       Date:  2020-08-20       Impact factor: 4.162

6.  Drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction.

Authors:  Lin Chen; Jie Deng; Ailing Yu; Yuhan Hu; Bo Jin; Pengyuan Du; Jianhong Zhou; Lei Lei; Yuan Wang; Serhii Vakal; Xingyi Li
Journal:  Bioact Mater       Date:  2021-09-10

Review 7.  Ocular Drug Delivery: Advancements and Innovations.

Authors:  Bo Tian; Evan Bilsbury; Sean Doherty; Sean Teebagy; Emma Wood; Wenqi Su; Guangping Gao; Haijiang Lin
Journal:  Pharmaceutics       Date:  2022-09-13       Impact factor: 6.525

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.